This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Lunan Pharmaceutical Group Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chenghong Sun: Innovator in Medical Applications of Icaritin
Introduction
Chenghong Sun is a notable inventor based in Linyi, China. He has made significant contributions to the field of medicine, particularly through his innovative work involving the compound icaritin. His research focuses on the medical use of this compound in treating various bleeding disorders.
Latest Patents
Chenghong Sun holds a patent for the medical use of icaritin. This patent outlines the use of icaritin in preparing a drug aimed at preventing and treating bleeding disorders. The invention is particularly relevant for conditions such as hemorrhagic transformation after cerebral infarction and gastrointestinal bleeding caused by thrombolytic or antithrombotic drugs. The patent emphasizes that icaritin can relieve platelet dysfunction, shorten thromboplastin time, and promote blood coagulation.
Career Highlights
Chenghong Sun is affiliated with Lunan Pharmaceutical Group Corporation, where he applies his expertise in medicinal chemistry. His work has led to advancements in therapeutic options for patients suffering from bleeding complications. With 1 patent to his name, he continues to push the boundaries of medical research.
Collaborations
Chenghong has collaborated with notable colleagues, including Sina Pan and Jingchun Yao. Their combined efforts contribute to the ongoing research and development in the field of medicine.
Conclusion
Chenghong Sun's innovative work with icaritin showcases his commitment to improving medical treatments for bleeding disorders. His contributions are vital in advancing therapeutic options and enhancing patient care.